Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Lupus patients wanted for landmark study on disease patterns

NCT ID NCT06804057

First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 30 times

Summary

This study is a registry that will follow 1,000 adults with systemic lupus erythematosus (SLE) over time. Researchers will collect information during routine doctor visits to learn more about how lupus presents, is managed, and what outcomes patients experience. No new drugs or treatments are being tested.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CorEvitas

    RECRUITING

    Waltham, Massachusetts, 02451, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this registry could provide a clearer picture of how lupus progresses and how it is managed in real-world settings, potentially guiding future treatment strategies.

What could go wrong

This is an observational study, not a clinical trial testing a new therapy. It will not directly lead to a new treatment or cure, and results may take years to emerge.

Conditions

The condition(s) this trial relates to.

systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.